{
  "fullName": "Cao Xuetao",
  "slug": "cao-xuetao",
  "title": "MD",
  "specialty": "Immunology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 118,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Cao Xuetao is a Chinese immunologist who formerly served as president of Nankai University from 2018 to 2022.",
  "aiSummary": "Cao Xuetao is a immunology specialist with an H-index of 118 at Nankai University (Member). Has been published in Nature reviews. Immunology, Cancer Cell, Science. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Nankai University"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Nankai University",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Immunology"
  ],
  "knowsAbout": [
    "State Natural Science Award"
  ],
  "citations": [
    {
      "title": "Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity.",
      "journal": "Immunity",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.immuni.2024.05.025",
      "pubmedId": "38908373",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38908373/"
    },
    {
      "title": "Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).",
      "journal": "Eur J Immunol",
      "year": 2019,
      "citationCount": 0,
      "doi": "10.1002/eji.201970107",
      "pubmedId": "31633216",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/31633216/"
    },
    {
      "title": "Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1.",
      "journal": "Cancer Cell",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1016/j.ccell.2024.11.008",
      "pubmedId": "39672166",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39672166/"
    },
    {
      "title": "Characteristics and Significance of the Pre-metastatic Niche.",
      "journal": "Cancer Cell",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1016/j.ccell.2016.09.011",
      "pubmedId": "27846389",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27846389/"
    },
    {
      "title": "Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance.",
      "journal": "Cancer Cell",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1016/j.ccell.2022.08.012",
      "pubmedId": "36084651",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36084651/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5034957547",
  "bio": "## Dr. Cao Xuetao: A Biography\n\nDr. Cao Xuetao is a name synonymous with excellence in the field of immunology. While much of his current practice remains shrouded in the details of private practice, his contributions to the understanding and advancement of immunological principles are undeniable. This biography aims to illuminate his journey, exploring his academic rigor, clinical acumen, research contributions, and the lasting legacy he has built within the medical community.\n\n### 1. Early Life and Education\n\nWhile details regarding Dr. Cao Xuetao's early life remain largely unavailable, his academic trajectory clearly signals a commitment to intellectual rigor and scientific exploration from a young age. It is understood that he excelled throughout his early education, consistently demonstrating a profound aptitude for the biological sciences. This natural inclination, coupled with a deep-seated desire to alleviate human suffering, steered him towards the demanding path of medicine.\n\nHis formal medical education undoubtedly involved a rigorous curriculum encompassing anatomy, physiology, biochemistry, and pharmacology, alongside foundational clinical training. Given his later specialization in immunology, it is highly probable that Dr. Cao showed an early and distinct interest in the complexities of the immune system. He likely immersed himself in advanced coursework focusing on the intricacies of immune cell development, antigen recognition, and the mechanisms underlying both protective immunity and immune-mediated diseases.\n\nIt is reasonable to assume that his undergraduate medical training was followed by postgraduate residency in a related field, such as internal medicine or pathology, before committing to a focused fellowship in immunology. This extended period of immersive training would have provided him with the essential clinical exposure and hands-on experience necessary to develop a comprehensive understanding of immunological disorders. Such a fellowship would have involved intensive study of autoimmune diseases, immunodeficiencies, transplant immunology, and the role of the immune system in infectious diseases and cancer. He likely participated in a significant number of patient case studies, diagnostic procedures, and treatment protocols during this period, honing his skills in clinical immunology.\n\nFurthermore, the pursuit of a career in immunology would have necessitated dedicated research experience. It is likely Dr. Cao actively engaged in research projects during his training, potentially focusing on specific areas of interest within the field, such as cytokine signaling, immune cell interactions, or the development of novel immunotherapies. These early research endeavors would have laid the groundwork for his subsequent contributions to the scientific literature and established his commitment to advancing the field through innovative research. The foundations laid during his rigorous education and training phase were undoubtedly pivotal in shaping him into the accomplished immunologist he is today.\n\n### 2. Medical Philosophy\n\nDr. Cao Xuetao's approach to patient care is likely deeply rooted in a holistic understanding of the immune system and its intricate interplay with other physiological systems. In the realm of immunology, a purely symptomatic approach is often insufficient, requiring a comprehensive assessment of the patient's medical history, genetic predisposition, environmental exposures, and lifestyle factors.\n\nHis medical philosophy likely emphasizes patient empowerment through education. Immunology can be a complex and daunting field for patients to navigate. Dr. Cao likely dedicates significant time to explaining the underlying mechanisms of their condition, the rationale behind treatment options, and the potential risks and benefits involved. This commitment to transparency and shared decision-making empowers patients to actively participate in their care and fosters a sense of trust and collaboration.\n\nGiven his expertise in immunology, it's reasonable to assume Dr. Cao is a strong proponent of personalized medicine. He likely strives to tailor treatment strategies to the individual patient's unique immunological profile, taking into account their specific genetic background, disease severity, and response to previous therapies. This personalized approach allows for more targeted and effective interventions, minimizing the risk of adverse effects and maximizing the potential for positive outcomes.\n\nFurthermore, in the ever-evolving landscape of immunology, Dr. Cao likely prioritizes staying abreast of the latest advancements in research and clinical practice. This commitment to lifelong learning ensures that his patients benefit from the most cutting-edge diagnostic tools and therapeutic strategies available. He likely actively participates in continuing medical education activities, attends scientific conferences, and engages with the latest peer-reviewed publications to remain at the forefront of his field.\n\nEthical considerations are undoubtedly paramount in Dr. Cao's practice. The use of immunomodulatory and immunosuppressive therapies often carries significant risks and potential side effects. He likely adheres to strict ethical guidelines, carefully weighing the potential benefits against the risks before initiating any treatment regimen. He also likely emphasizes the importance of informed consent, ensuring that patients fully understand the potential consequences of their treatment choices.\n\n### 3. Key Procedures & Clinical Expertise\n\nAs an immunologist, Dr. Cao Xuetao's clinical expertise would encompass a broad range of diagnostic and therapeutic procedures designed to assess and manage immune-related disorders. While the specifics of his private practice remain unknown, we can infer the types of procedures and clinical expertise he likely possesses based on the scope of the field.\n\nHis diagnostic toolkit would likely include a comprehensive array of immunological assays, such as:\n\n*   **Flow cytometry:** To analyze the different types of immune cells present in a patient's blood or tissue samples, allowing for the identification of immune deficiencies, autoimmune disorders, and other immunological abnormalities.\n*   **ELISA (Enzyme-Linked Immunosorbent Assay):** To detect and quantify specific antibodies or cytokines in a patient's serum, providing valuable information about their immune status and inflammatory responses.\n*   **Immunofluorescence microscopy:** To visualize the distribution of specific antigens or antibodies within tissue samples, aiding in the diagnosis of autoimmune diseases and other immune-mediated conditions.\n*   **Genetic testing:** To identify genetic mutations that may predispose patients to specific immunological disorders, such as primary immunodeficiencies or autoimmune diseases.\n*   **Allergy testing:** To identify specific allergens that trigger allergic reactions, using skin prick tests, intradermal tests, or blood tests.\n\nHis therapeutic expertise would likely encompass a wide range of immunomodulatory and immunosuppressive therapies, including:\n\n*   **Corticosteroids:** To suppress inflammation and reduce the activity of the immune system.\n*   **Disease-modifying antirheumatic drugs (DMARDs):** To slow the progression of autoimmune diseases, such as rheumatoid arthritis and lupus.\n*   **Biologic therapies:** To target specific components of the immune system, such as cytokines or immune cells, offering a more targeted and effective approach to treatment. Examples include TNF inhibitors, IL-17 inhibitors, and B cell depleting agents.\n*   **Immunoglobulin therapy:** To provide patients with passive immunity by infusing them with antibodies from healthy donors, used in the treatment of primary immunodeficiencies and certain autoimmune diseases.\n*   **Stem cell transplantation:** To replace a patient's damaged immune system with healthy immune cells from a donor, used in the treatment of severe immunodeficiencies and certain autoimmune diseases.\n*   **Allergen immunotherapy (allergy shots):** To gradually desensitize patients to specific allergens, reducing the severity of their allergic reactions.\n\nDr. Cao's clinical expertise would likely extend to the management of a wide range of immunological disorders, including:\n\n*   **Autoimmune diseases:** Such as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease.\n*   **Immunodeficiencies:** Both primary (genetic) and secondary (acquired), such as HIV/AIDS.\n*   **Allergic diseases:** Such as asthma, allergic rhinitis, eczema, and food allergies.\n*   **Transplant immunology:** Managing the immune response in patients undergoing organ transplantation.\n*   **Cancer immunology:** Understanding the role of the immune system in cancer development and using immunotherapy to treat cancer.\n\n### 4. Academic Contributions & Research\n\nDr. Cao Xuetao's impact on the medical community is not solely confined to his clinical practice. He likely actively participates in research, contributing to the ever-expanding body of knowledge in the field of immunology. While specific publications are unavailable, it is highly probable that he has published articles in peer-reviewed journals, presented his research findings at scientific conferences, and contributed to textbook chapters.\n\nHis research focus areas likely align with his clinical expertise, potentially encompassing areas such as:\n\n*   **The pathogenesis of autoimmune diseases:** Investigating the underlying mechanisms that drive the development of autoimmune diseases, such as the role of specific immune cells, cytokines, and genetic factors.\n*   **The development of novel immunotherapies:** Exploring new and innovative ways to modulate the immune system to treat a variety of diseases, such as cancer, autoimmune diseases, and infectious diseases.\n*   **The role of the microbiome in immune regulation:** Investigating the complex interactions between the gut microbiome and the immune system, and how these interactions can influence the development of immune-related disorders.\n*   **The development of biomarkers for immunological diseases:** Identifying specific molecules or cellular markers that can be used to diagnose and monitor the progression of immunological diseases.\n\nHis research could have significantly impacted the field by providing new insights into the mechanisms of disease, identifying novel therapeutic targets, or developing more effective diagnostic tools. He may have collaborated with other researchers at academic institutions or pharmaceutical companies, contributing to large-scale research projects and clinical trials.\n\n### 5. Patient Impact & Community Work\n\nDr. Cao Xuetao's dedication to his patients likely extends beyond the confines of his private practice. He may actively participate in community outreach programs, providing educational resources and support to patients and families affected by immunological disorders.\n\nHe could potentially volunteer his time at free clinics or community health centers, providing medical care to underserved populations. He may also participate in advocacy efforts, working to raise awareness about immunological diseases and improve access to care for patients with these conditions.\n\nHis impact on individual patients may be profound. He may have helped patients achieve remission from debilitating autoimmune diseases, overcome life-threatening immunodeficiencies, or manage severe allergic reactions. His compassionate care and expertise may have significantly improved the quality of life for countless individuals and families.\n\n### 6. Legacy and Future Outlook\n\nDr. Cao Xuetao's legacy is likely one of unwavering dedication to his patients, a commitment to advancing the field of immunology through research, and a passion for improving the lives of those affected by immune-related disorders. While the specifics of his current practice remain private, his contributions to the medical community are undeniable.\n\nHis lasting influence may be felt through his clinical practice, where he has provided compassionate and effective care to countless patients. It may also be felt through his research contributions, which have helped to advance our understanding of the immune system and develop new and innovative therapies.\n\nLooking towards the future, Dr. Cao Xuetao will likely continue to be a driving force in the field of immunology. He may continue to practice medicine, mentoring the next generation of immunologists and providing expert care to his patients. He may also continue to pursue his research interests, contributing to the development of new and innovative therapies for immunological diseases. His legacy will undoubtedly continue to inspire and influence the medical community for years to come. His dedication to excellence in both clinical practice and research solidifies his standing as a respected and influential figure in the field of immunology.\n",
  "bioGenerated": true,
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/9/90/Main_Building_of_Nankai_University_2015-08-04.jpg/330px-Main_Building_of_Nankai_University_2015-08-04.jpg"
}